利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

18 条记录 (耗时 0.017 秒)

    ELECTRICALLY PROGRAMMABLE FUSE CONTROLLER FOR INTEGRATED CIRCUIT IDENTIFICATION, METHOD OF OPERATION THEREOF AND INTEGRATED CIRCUIT INCORPORATING THE SAME
    4.
    发明申请
    ELECTRICALLY PROGRAMMABLE FUSE CONTROLLER FOR INTEGRATED CIRCUIT IDENTIFICATION, METHOD OF OPERATION THEREOF AND INTEGRATED CIRCUIT INCORPORATING THE SAME 审中-公开
    用于集成电路识别的电可编程保险丝控制器及其运算方法和集成电路的集成电路

    公开(公告)号：US20110279171A1

    公开(公告)日：2011-11-17

    申请号：US12778305

    申请日：2010-05-12

    申请人： Lihui Cao ,  Saket K. Goyal ,  Thai-Minh Nguyen

    发明人： Lihui Cao ,  Saket K. Goyal ,  Thai-Minh Nguyen

    IPC分类号： H01H37/76

    CPC分类号： G11C7/20 ,  G11C17/16 ,  G11C2029/4402

    摘要： An electrically programmable fuse controller, a method of controlling a drive voltage of an integrated circuit (IC) and an IC incorporating the controller or the method. In one embodiment, the controller includes a VID eFuse controller configured to receive and write a voltage identifier to an associated eFuse and thereafter allow the voltage identifier to be read from the eFuse and employed to set a drive voltage of an integrated circuit associated with the VID eFuse controller.

    摘要翻译： 一种电可编程熔丝控制器，一种控制集成电路（IC）的驱动电压的方法和结合了该控制器或该方法的IC。 在一个实施例中，控制器包括VID eFuse控制器，其被配置为将电压标识符接收并写入相关联的eFuse，然后允许从eFuse读取电压标识符，并用于设置与VID相关联的集成电路的驱动电压 eFuse控制器。

    Drug Delivery System for Retarding Release of Water Soluble Drugs
    7.
    发明申请
    Drug Delivery System for Retarding Release of Water Soluble Drugs 审中-公开
    用于阻止水溶性药物释放的药物输送系统

    公开(公告)号：US20070172509A1

    公开(公告)日：2007-07-26

    申请号：US11626785

    申请日：2007-01-24

    申请人： Thai Minh Nguyen ,  Theodore L. Parker ,  John F. Shanley

    发明人： Thai Minh Nguyen ,  Theodore L. Parker ,  John F. Shanley

    IPC分类号： A61K31/727 ,  A61K31/65 ,  A61K31/60 ,  A61K31/519 ,  A61K38/28

    CPC分类号： A61K38/28 ,  A61K9/0024 ,  A61K31/519 ,  A61K31/60 ,  A61K31/65 ,  A61K31/727 ,  A61L31/08 ,  A61L31/10 ,  A61L31/16 ,  A61L2300/416 ,  A61L2300/42 ,  A61L2300/43 ,  A61L2300/602 ,  C08L67/04

    摘要： An implantable drug delivery system uses a hydrophobic compound as an outer layer or barrier for retarding release of water soluble drugs from the implantable system. The system includes an inner portion of a water soluble drug in a drug matrix material which stabilizes the drug. An outer portion of the drug delivery system separates the inner portion from a surrounding environment. The outer portion retards the release of the water soluble drug from the inner portion. The outer portion includes a hydrophobic non-polymer compound and a binder. The hydrophobic compound can be another drug which can be delivered at an entirely different release kinetic from the water soluble drug and for treatment of the same or a different condition. When the drug delivery system is implanted in a body the outer portion retards the release of the water soluble drug by controlling fluid passing from the body into the inner portion and by controlling passage of the water soluble drug from the inner portion into the body.

    摘要翻译： 可植入药物递送系统使用疏水性化合物作为外层或屏障来阻止水溶性药物从可植入系统的释放。 该系统包括使药物稳定的药物基质材料中的水溶性药物的内部。 药物递送系统的外部部分将内部部分与周围环境分开。 外部部分阻止水溶性药物从内部的释放。 外部部分包括疏水性非聚合物和粘合剂。 疏水化合物可以是另一种药物，其可以以与水溶性药物完全不同的释放动力学递送并用于治疗相同或不同的病症。 当药物递送系统植入体内时，外部通过控制从身体流入内部的流体并通过控制水溶性药物从内部部分进入体内来阻止水溶性药物的释放。